HomeFRX • TSE
Fennec Pharmaceuticals Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 7.93M | -18.59% |
Operating expense | 8.19M | -24.64% |
Net income | -1.99M | 25.99% |
Net profit margin | -25.05 | 9.07% |
Earnings per share | -0.06 | 40.00% |
EBITDA | -909.00K | — |
Effective tax rate | -22.53% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.63M | 100.72% |
Total assets | 44.95M | 67.31% |
Total liabilities | 50.82M | 32.04% |
Total equity | -5.87M | — |
Shares outstanding | 27.59M | — |
Price to book | -35.48 | — |
Return on assets | -4.50% | — |
Return on capital | -11.56% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.99M | 25.99% |
Cash from operations | -1.47M | 69.67% |
Cash from investing | — | — |
Cash from financing | -12.21M | -313.12% |
Net change in cash | -13.69M | -1,673.10% |
Free cash flow | -1.11M | 73.64% |
Previous close
$7.45
Day range
$7.23 - $7.58
Year range
$5.65 - $14.67
Market cap
209.57M CAD
Avg Volume
617.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1996
Headquarters
Website
Employees
32
